Normal Hemostasis Values in Premature Infants

Recruiting now

Conditions studied: Premature Infant, Hemostasis

In brief

This study aims to retrospectively determine, in a large cohort of apparently healthy children born before 37 weeks of gestation, the expected values of certain hemostasis parameters from birth to 18 months (when they start walking), and to determine whether or not they differ from those of full-term infants.

Key facts

Study ID

NCT07349251

Run by

University Hospital, Strasbourg, France

People needed

1000

Starts

2025-11-24

Expected to finish

2031-11-24

Last updated by the study team

2026-01-16

Who can join

Age: any, up to 2. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged 18 months or younger for whom a sample was sent to the Hematology Laboratory at Strasbourg University Hospital for measurement of a hemostasis parameter

You may not qualify if…

• Patients with incomplete data
• Patients with a congenital hemostasis disorder (hemophilia A or B, von Willebrand disease), a coagulopathy, or hepatocellular insufficiency

Where it is running

• Laboratoire d'Hématologie - CHU de Strasbourg - France — Strasbourg, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.